MetaADEDB 2.0 @ LMMD
Vincristine
(AQTQHPDCURKLKT-PNYVAJAMSA-N)
Structure
SMILES
OS(=O)(=O)O.O=CN1c2cc(OC)c(cc2[C@]23[C@@H]1[C@@](O)(C(=O)OC)[C@H](OC(=O)C)[C@]1([C@@H]3N(CC2)CC=C1)CC)[C@]1(C[C@H]2CN(CCc3c1[nH]c1c3cccc1)C[C@](C2)(O)CC)C(=O)OC
Molecular Formula:
C46H58N4O14S
Molecular Weight:
923.036
Log P:
4.5222
Hydrogen Bond Acceptor:
17
Hydrogen Bond Donor:
5
TPSA:
254.15
CAS Number(s):
2068-78-2
Synonym(s)
1.
Vincristine
2.
Leurocristine
3.
Citomid
4.
Farmistin
5.
Oncovin
6.
Oncovine
7.
Onkocristin
8.
Vincasar
9.
Vincasar PFS
10.
Vincristin Bristol
11.
Vincristin medac
12.
Vincristine Sulfate
13.
Vincrisul
14.
Vintec
15.
cellcristin
16.
PFS, Vincasar
17.
Sulfate, Vincristine
External Link(s)
MeSHD014750
PubChem Compound5388992
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Alanine Aminotransferase IncreasedFAERS: 2US FAERS
2Aspartate Aminotransferase IncreasedFAERS: 2US FAERS
3Acute myocardial infarctionFAERS: 1US FAERS
4AstheniaFAERS: 1US FAERS
5CellulitisFAERS: 1US FAERS
6Disease ProgressionFAERS: 1US FAERS
7Disease recurrenceFAERS: 1US FAERS
8Drug administration errorFAERS: 1US FAERS
9Enterococcal infectionFAERS: 1US FAERS
10Febrile NeutropeniaFAERS: 1US FAERS
11General physical health deteriorationFAERS: 1US FAERS
12Incorrect route of drug administrationFAERS: 1US FAERS
13InfectionFAERS: 1US FAERS
14Injection site erythemaFAERS: 1US FAERS
15Injection site extravasationFAERS: 1US FAERS
16Injection site vesiclesFAERS: 1US FAERS
17Lung AbscessFAERS: 1US FAERS
18LymphadenopathyFAERS: 1US FAERS
19Malignant neoplasm progressionFAERS: 1US FAERS
20MalnutritionFAERS: 1US FAERS
21Metapneumovirus infectionFAERS: 1US FAERS
22MoaningFAERS: 1US FAERS
23MonoplegiaFAERS: 1US FAERS
24PainFAERS: 1US FAERS
25PancytopeniaFAERS: 1US FAERS
26PneumoniaFAERS: 1US FAERS
27Rhinovirus infectionFAERS: 1US FAERS
28SepsisFAERS: 1US FAERS
29Toxic Shock SyndromeFAERS: 1US FAERS
30Weight decreasedFAERS: 1US FAERS
31Wrong drug administeredFAERS: 1US FAERS
32DisorientationCanada Vigilance: 1Canada Vigilance
33HemiplegiaCanada Vigilance: 1Canada Vigilance
34HypotensionCanada Vigilance: 1Canada Vigilance
35Injection site painCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.